EDGAR Filing Documents for 0001104659-16-152647

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:

SEC Accession No. 0001104659-16-152647

Filing Date

2016-10-28

Accepted

2016-10-27 17:52:17

Documents

Period of Report

2016-10-01

Document Format Files

Seq	Description	Document	Type	Size
1	6-K	a16-19793_16k.htm	6-K	22823
2	EX-99.1	a16-19793_1ex99d1.htm	EX-99.1	13255
3	EX-99.2	a16-19793_1ex99d2.htm	EX-99.2	175610
4	EX-99.3	a16-19793_1ex99d3.htm	EX-99.3	116480
5	EX-99.4	a16-19793_1ex99d4.htm	EX-99.4	180110
6	EX-99.5	a16-19793_1ex99d5.htm	EX-99.5	272733
7	GRAPHIC	g197931mmi001.gif	GRAPHIC	3220
	Complete submission text file	0001104659-16-152647.txt		786761

Mailing Address C/O NORTON ROSE FULBRIGHT CANADA LLP 1 PLACE VILLE MARIE, SUITE 2500 MONTREAL A8 H3B 1R1

Business Address C/O NORTON ROSE FULBRIGHT CANADA LLP 1 PLACE VILLE MARIE, SUITE 2500 MONTREAL A8 H3B 1R1 843-900-3211

Aeterna Zentaris Inc. (Filer) CIK: 0001113423 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 000-30752 | Film No.: 161956474
SIC: 2834 Pharmaceutical Preparations